Skip to main content

Publications

featured publications
  • The role of variant alleles of the mannose-binding lectin in the inhibitor development in severe hemophilia A.

    Thrombosis research

    Authors: Gudrun Ulrich-Merzenich, Annekristin Hausen, Heike Zeitler, Georg Goldmann, Johannes Oldenburg, Anna Pavlova

    View this publication
  • The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Manuel Carcao, Carmen Escuriola-Ettingshausen, Elena Santagostino, Johannes Oldenburg, Ri Liesner, Beatrice Nolan, Angelika Bátorová, Saturnino Haya, Guy Young

    View this publication
  • [Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren].

    Hamostaseologie

    Authors: Hermann Eichler, Manuela Albisetti Pedroni, Susan Halimeh, Christoph Königs, Florian Langer, Wolfgang Miesbach, Johannes Oldenburg, Ute Scholz, Werner Streif, Robert Klamroth

    View this publication
  • Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Johnny Mahlangu, Johannes Oldenburg, Michael U Callaghan, Midori Shima, Maria Elisa Mancuso, Peter Trask, Michael Recht, Claudia Garcia, Renchi Yang, Michaela Lehle, Harrison Macharia, Elina Asikanius, Gallia G Levy, Rebecca Kruse-Jarres, Sylvia von Mackensen

    View this publication
  • Disruption of Structural Disulfides of Coagulation FXIII-B Subunit; Functional Implications for a Rare Bleeding Disorder.

    International journal of molecular sciences

    Authors: Sneha Singh, Mohammad Suhail Akhter, Johannes Dodt, Amit Sharma, Senthilvelrajan Kaniyappan, Hamideh Yadegari, Vytautas Ivaskevicius, Johannes Oldenburg, Arijit Biswas

    View this publication
  • Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII.

    Patient preference and adherence

    Authors: Susan Kearney, Leslie J Raffini, Tan P Pham, Xin Ying Lee, Sylvia von Mackensen, Andrea Landorph, Hideyuki Takedani, Johannes Oldenburg

    View this publication
  • Detailed methylation map of LINE-1 5'-promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity.

    Molecular genetics & genomic medicine

    Authors: Amit Sharma, Muhammad A Jamil, Nicole Nuesgen, Albertas Dauksa, Antanas Gulbinas, Wolfgang A Schulz, Johannes Oldenburg, Osman El-Maarri

    View this publication
  • Correction to: Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.

    Thrombosis journal

    Authors: Arshi Naz, Arijit Biswas, Tehmina Nafees Khan, Anne Goodeve, Nisar Ahmed, Nazish Saqlain, Shariq Ahmed, Ikram Din Ujjan, Tahir S Shamsi, Johannes Oldenburg

    View this publication
  • Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function.

    Journal of medicinal chemistry

    Authors: Charlotte A Bäuml, Thomas Schmitz, Ajay Abisheck Paul George, Monica Sudarsanam, Kornelia Hardes, Torsten Steinmetzer, Lori A Holle, Alisa S Wolberg, Bernd Pötzsch, Johannes Oldenburg, Arijit Biswas, Diana Imhof

    View this publication
  • Rapid and sustained immune tolerance to inhibitors induced by a plasma-derived, VWF-containing FVIII concentrate.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Elena Santagostino, Savita Rangarajan, Johannes Oldenburg, Roser Peiró-Jordan, Víctor Jiménez-Yuste

    View this publication